JP2003500059A - 生物活性タンパク質およびペプチドのファージ依存大量生成 - Google Patents

生物活性タンパク質およびペプチドのファージ依存大量生成

Info

Publication number
JP2003500059A
JP2003500059A JP2000620108A JP2000620108A JP2003500059A JP 2003500059 A JP2003500059 A JP 2003500059A JP 2000620108 A JP2000620108 A JP 2000620108A JP 2000620108 A JP2000620108 A JP 2000620108A JP 2003500059 A JP2003500059 A JP 2003500059A
Authority
JP
Japan
Prior art keywords
host cell
phage
bacteriophage
cells
temperature
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000620108A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003500059A5 (https=
Inventor
クルジユム，ビタリイ・アー
チエルニフ，スベトラーナ・イー
スラブチエンコ，イリーナ・ユー
ボジアノフ，オレクサンドル・エフ
Original Assignee
フエイジ・バイオテクノロジー・コーポレイシヨン
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by フエイジ・バイオテクノロジー・コーポレイシヨン filed Critical フエイジ・バイオテクノロジー・コーポレイシヨン
Publication of JP2003500059A publication Critical patent/JP2003500059A/ja
Publication of JP2003500059A5 publication Critical patent/JP2003500059A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/06—Lysis of microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/73—Expression systems using phage (lambda) regulatory sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10111—Myoviridae
    • C12N2795/10141—Use of virus, viral particle or viral elements as a vector
    • C12N2795/10143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
JP2000620108A 1999-05-25 2000-05-24 生物活性タンパク質およびペプチドのファージ依存大量生成 Pending JP2003500059A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/318,288 US6268178B1 (en) 1999-05-25 1999-05-25 Phage-dependent super-production of biologically active protein and peptides
US09/318,288 1999-05-25
PCT/US2000/040020 WO2000071731A1 (en) 1999-05-25 2000-05-24 Phage-dependent super-production of biologically active protein and peptides

Publications (2)

Publication Number Publication Date
JP2003500059A true JP2003500059A (ja) 2003-01-07
JP2003500059A5 JP2003500059A5 (https=) 2007-07-19

Family

ID=23237514

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000620108A Pending JP2003500059A (ja) 1999-05-25 2000-05-24 生物活性タンパク質およびペプチドのファージ依存大量生成

Country Status (7)

Country Link
US (2) US6268178B1 (https=)
EP (1) EP1180153B1 (https=)
JP (1) JP2003500059A (https=)
AT (1) ATE293170T1 (https=)
AU (1) AU5049100A (https=)
DE (1) DE60019411T2 (https=)
WO (1) WO2000071731A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7252818B2 (en) * 1998-07-24 2007-08-07 Cardiovascular Biotherapeutics, Inc. Method of producing biologically active human acidic fibroblast growth factor and its use in promoting angiogenesis
US6268178B1 (en) * 1999-05-25 2001-07-31 Phage Biotechnology Corp. Phage-dependent super-production of biologically active protein and peptides
JP2004517607A (ja) * 2000-08-15 2004-06-17 ファージ バイオテクノロジー コーポレイション 生物学的に活性なヒト酸性線維芽細胞成長因子の産生方法および血管新生の促進におけるその使用
EP1309604B1 (en) * 2000-08-15 2007-03-28 Phage Biotechnology Corporation Phage-dependent superproduction of biologically active protein and peptides
WO2004027064A2 (en) * 2002-09-18 2004-04-01 Centre Hospitalier De L'universite De Montreal (Chum) Ghrh analogues
WO2019068006A1 (en) * 2017-09-29 2019-04-04 The Charles Stark Draper Laboratory, Inc. CELLULAR LYSE CONTROLLED BY STIMULUS

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1089119A1 (ru) * 1982-11-29 1984-04-30 Институт Молекулярной Биологии И Генетики Ан Усср Способ получени @ -лактамазы

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE276694C (https=)
IL59007A (en) 1978-12-22 1983-11-30 Biogen Nv Recombinant dna molecules coding for polypeptides displaying hepatitis b virus antigenicity,method of their production and compositions containing the same
CH657141A5 (de) 1980-07-01 1986-08-15 Hoffmann La Roche Dns-sequenzen, rekombinante expressionsvektoren zur mikrobiellen herstellung von human-leukozyten-interferonen und transformierte mikroorganismen.
US4775622A (en) 1982-03-08 1988-10-04 Genentech, Inc. Expression, processing and secretion of heterologous protein by yeast
CA1209501A (en) 1982-09-16 1986-08-12 Nikos Panayotatos Expression vector
JPS5979746A (ja) 1982-10-30 1984-05-09 Mitsubishi Heavy Ind Ltd 加硫機用制御装置
GB2143238A (en) 1983-03-31 1985-02-06 Dr Anthony Stuart Breeze A method for enzyme liberation from bacterial cells
US4637980A (en) 1983-08-09 1987-01-20 Smithkline Beckman Corporation Externalization of products of bacteria
CA1309044C (en) 1987-11-09 1992-10-20 Toshiya Takano Method of producing foreign gene products
IL92124A (en) 1988-10-28 1996-10-31 Sidney Pestka Recombinant proteins modified to contain post-phosphorylation that do not occur in nature
US5102797A (en) 1989-05-26 1992-04-07 Dna Plant Technology Corporation Introduction of heterologous genes into bacteria using transposon flanked expression cassette and a binary vector system
US5196318A (en) 1990-06-26 1993-03-23 The Texas A&M University System Precisely regulated expression of deleterious genes
NZ241311A (en) 1991-01-17 1995-03-28 Gen Hospital Corp Rna sequence having trans-splicing activity, plant strains
US5346830A (en) 1991-06-11 1994-09-13 The Center For Innovative Technology Gene expression system based on regulatory elements of bateriophage P2 and satellite phage P4
US5834233A (en) 1992-04-06 1998-11-10 Gx Biosystems A/S Method of limiting the survival of genetically engineered microorganisms in their enivronment
US5622852A (en) 1994-10-31 1997-04-22 Washington University Bcl-x/Bcl-2 associated cell death regulator
US5861273A (en) 1993-12-21 1999-01-19 Celtrix Phamraceuticals, Inc. Chromosomal expression of heterologous genes in bacterial cells
US6268178B1 (en) * 1999-05-25 2001-07-31 Phage Biotechnology Corp. Phage-dependent super-production of biologically active protein and peptides
EP1309604B1 (en) * 2000-08-15 2007-03-28 Phage Biotechnology Corporation Phage-dependent superproduction of biologically active protein and peptides
JP2004517607A (ja) * 2000-08-15 2004-06-17 ファージ バイオテクノロジー コーポレイション 生物学的に活性なヒト酸性線維芽細胞成長因子の産生方法および血管新生の促進におけるその使用

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1089119A1 (ru) * 1982-11-29 1984-04-30 Институт Молекулярной Биологии И Генетики Ан Усср Способ получени @ -лактамазы

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JPN6010007923, Ｇｅｎｅ， ２［２］（１９７７） ｐ．９５−１１３ *
JPN6010007925, Ｃｈｉｎ． Ｊ． Ｂｉｏｔｅｃｈｎｏｌ．， １２［１］（１９９６） ｐ．２５−２９ *

Also Published As

Publication number Publication date
EP1180153B1 (en) 2005-04-13
US20010044133A1 (en) 2001-11-22
DE60019411D1 (de) 2005-05-19
US6268178B1 (en) 2001-07-31
US6794162B2 (en) 2004-09-21
EP1180153A1 (en) 2002-02-20
ATE293170T1 (de) 2005-04-15
DE60019411T2 (de) 2006-03-09
AU5049100A (en) 2000-12-12
WO2000071731A1 (en) 2000-11-30

Similar Documents

Publication Publication Date Title
EP1309604B1 (en) Phage-dependent superproduction of biologically active protein and peptides
JP2721139B2 (ja) 動物のインターフェロン
JPH0665305B2 (ja) 組換えｄｎａ含有宿主細胞の安定化法
NZ198445A (en) Production of human fibroblast interferon by recombinant dna technology
JPH05501360A (ja) ＩｇＡプロテアーゼによる組み換えタンパク質の酵素的切断法
AU2001284914A1 (en) Phage-dependent Superproduction of Biologically Active Protein and Peptides
JPH0515435B2 (https=)
JP2003500059A (ja) 生物活性タンパク質およびペプチドのファージ依存大量生成
EP0342892B1 (en) Extraction of human interleukin-4 from bacteria
JPS6156199A (ja) 新規ヒトインタ−フエロンα類
JPH02195888A (ja) ヒトインターロイキン２活性を有するポリペプチドをコードする遺伝子を含有する組換えｄｎａ体および該組換えｄｎａ体により形質転換された原核生物細胞
CN118978603A (zh) 芋螺毒素融合蛋白mgs-afp3(r509y)及其制备方法和应用
GB2112395A (en) Recombinant cloning vector
JPS62155080A (ja) 新規な大腸菌宿主
JPS61187794A (ja) Ｂ型肝炎表面抗原をコ−ドするベクタ−
JPS5888399A (ja) 宿主微生物の形質転換に適当な組換えクロ−ニングベクタ−
JPH05310796A (ja) 新規なヒト細胞性フィブロネクチン

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070522

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070522

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20070608

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100216

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100510

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100517

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20101019